Generation Bio Co.

Pages

Generation Bio Co.

$GBIO

Search Table
Pages

Trade Date Insider Title Buy or Sell Quantity Security Type Price Proceeds Transaction Conviction Position Quantity Position Value Positon Conviction SEC Link Nature of Ownership
2020-06-16James E Flynn-Buy225,000Common Stock$19.00-$4,275,000.00  48.69    [ Very High ]1,186,215$22,538,085.00  256.68   [Very High]Form 4Through Deerfield Partners, L.P.
2020-06-16James E Flynn-Buy257,883Common Stock$0.00$0.00  -961,215$0.00  208.00   [Very High]Form 4Through Deerfield Partners, L.P.
2020-06-16James E Flynn-Buy703,332Common Stock$0.00$0.00  -703,332$0.00  152.19   [Very High]Form 4Through Deerfield Partners, L.P.
2020-06-16Zone Healthcare Holdings, Llc-Buy1,518,819Common Stock$0.00$0.00  -1,518,819$0.00  -Form 4-
2020-06-16Zone Healthcare Holdings, Llc-Buy400,000Common Stock$19.00-$7,600,000.00  -1,918,819$36,457,561.00  -Form 4-
2020-06-16William Seybold-Buy1,518,819Common Stock$0.00$0.00  -1,518,819$0.00  -Form 4-
2020-06-16William Seybold-Buy400,000Common Stock$19.00-$7,600,000.00  -1,918,819$36,457,561.00  -Form 4-
2020-06-16Invus Public Equities, L.p.-Buy2,014,191Common Stock$0.00$0.00  -2,014,191$0.00  -Form 4-
2020-06-16Invus Public Equities, L.p.-Buy800,000Common Stock$19.00-$15,200,000.00  -2,814,191$53,469,629.00  -Form 4-
2020-06-16Rowland Charles A Jr-Buy50,627Common Stock$0.00$0.00  -50,627$0.00  -Form 4-
2020-06-16Rowland Charles A Jr-Buy30,000Common Stock$19.00-$570,000.00  -80,627$1,531,913.00  -Form 4-
2020-06-16Gustav Christensen-Buy88,961Common Stock$0.00$0.00  -131,422$0.00  -Form 4-
2020-06-16Anthony G. Quinn-Buy30,376Common Stock$0.00$0.00  -72,837$0.00  -Form 4-
2020-06-16Capital, Llc Casdin-Buy961,215Common Stock$0.00$0.00  -961,215$0.00  -Form 4See Footnote
2020-06-16Capital, Llc Casdin-Buy650,000Common Stock$19.00-$12,350,000.00  -1,611,215$30,613,085.00  -Form 4See Footnote
2020-06-16Jason P Rhodes-Buy10,040,032Common Stock$0.00$0.00  -12,630,758$0.00  -Form 4See Footnote
2020-06-16Atlas Venture Fund X, L.p.-Buy10,040,032Common Stock$0.00$0.00  -12,630,758$0.00  -Form 4See Footnote
2020-06-16Catherine Stehman-breen-Buy5,062Common Stock$0.00$0.00  -47,523$0.00  -Form 4-
2020-06-16Geoff McdonoughSee RemarksBuy113,231Common Stock$0.00$0.00  -1,479,080$0.00  -Form 4-
2020-06-16Donald William Nicholson-Buy56,615Common Stock$0.00$0.00  -99,076$0.00  -Form 4-
2020-06-16Wellington Biomedical Innovation Master Investors (cayman) I L.p.-Buy1,012,546Common Stock$0.00$0.00  -1,012,546$0.00  -Form 4-
2020-06-16Wellington Biomedical Innovation Master Investors (cayman) I L.p.-Buy1,100,000Common Stock$19.00-$20,900,000.00  -2,112,546$40,138,374.00  -Form 4-
2020-08-14Mark D. AngelinoChief Operating OfficerBuy62,560Common Stock$0.60-$37,536.00  13.47    [ Very High ]345,637$207,382.20  74.45    [High]Form 4-
2020-12-10Matthew StantonChief Scientific OfficerBuy10,540Common Stock$0.60-$6,324.00  2.27     [ High ]208,694$125,216.40  44.86    [High]Form 4-
2020-12-10Matthew StantonChief Scientific OfficerSell5,318Common Stock$37.14$197,510.52  1.14     [ High ]203,376$7,553,384.64  43.72    [High]Form 4-
2020-12-10Matthew StantonChief Scientific OfficerSell4,402Common Stock$38.01$167,320.02  0.95     [ High ]198,974$7,563,001.74  42.78    [High]Form 4-
2020-12-10Matthew StantonChief Scientific OfficerSell820Common Stock$38.62$31,668.40  0.18     [ Low ]198,154$7,652,707.48  42.60    [High]Form 4-
2020-12-15Atlas Venture Fund X, L.p.-Sell1,151,882Common Stock$0.00$0.00  -11,478,876$0.00  2,467.73 [Very High]Form 4See Footnote
2020-12-15Mark D. AngelinoChief Operating OfficerBuy5,301Common Stock$4.59-$24,331.59  1.14     [ High ]350,938$1,610,805.42  75.44    [High]Form 4-
2020-12-15Mark D. AngelinoChief Operating OfficerSell4,401Common Stock$34.87$153,462.87  0.95     [ High ]346,537$12,083,745.19  74.50    [High]Form 4-
2020-12-15Mark D. AngelinoChief Operating OfficerSell900Common Stock$35.52$31,968.00  0.19     [ Low ]345,637$12,277,026.24  74.30    [High]Form 4-
2021-01-11Rowland Charles A Jr-Buy20,408Common Stock$24.50-$499,996.00  3.74     [ Very High ]101,035$2,475,357.50  18.53    [High]Form 4
2021-01-11Donald William Nicholson-Buy4,081Common Stock$24.50-$99,984.50  0.75     [ Average ]103,157$2,527,346.50  18.92    [High]Form 4
2021-01-11Matthew StantonCHIEF SCIENTIFIC OFFICERBuy14,820Common Stock$0.60-$8,892.00  2.72     [ Very High ]212,974$127,784.40  39.07    [High]Form 4
2021-01-11Matthew StantonCHIEF SCIENTIFIC OFFICERSell6,269Common Stock$27.18$170,391.42  1.15     [ High ]206,705$5,618,241.90  37.92    [High]Form 4
2021-01-11Matthew StantonCHIEF SCIENTIFIC OFFICERSell8,042Common Stock$28.02$225,336.84  1.48     [ High ]198,663$5,566,537.26  36.44    [High]Form 4
2021-01-11Matthew StantonCHIEF SCIENTIFIC OFFICERSell509Common Stock$28.77$14,643.93  0.09     [ Very Low ]198,154$5,700,890.58  36.35    [High]Form 4
2021-01-11Douglas KerrCHIEF MEDICAL OFFICERBuy11,267Common Stock$4.59-$51,715.53  2.07     [ High ]337,825$1,550,616.75  61.97    [High]Form 4
2021-01-11Douglas KerrCHIEF MEDICAL OFFICERSell6,246Common Stock$27.17$169,703.82  1.15     [ High ]331,579$9,009,001.43  60.82    [High]Form 4
2021-01-11Douglas KerrCHIEF MEDICAL OFFICERSell4,721Common Stock$28.05$132,424.05  0.87     [ High ]326,858$9,168,366.90  59.96    [High]Form 4
2021-01-11Douglas KerrCHIEF MEDICAL OFFICERSell300Common Stock$28.80$8,640.00  0.06     [ Very Low ]326,558$9,404,870.40  59.90    [High]Form 4
2021-01-13Geoff McdonoughPRESIDENT AND CEOSell275,000Common Stock$0.00$0.00  -1,204,080$0.00  220.87   [Very High]Form 4
2021-01-13Geoff McdonoughPRESIDENT AND CEOBuy275,000Common Stock$0.00$0.00  -275,000$0.00  50.44    [High]Form 4By 2020 Trust
2021-01-14Matthew StantonCHIEF SCIENTIFIC OFFICERBuy5,630Common Stock$0.60-$3,378.00  1.03     [ High ]203,784$122,270.40  37.38    [High]Form 4
2021-01-14Matthew StantonCHIEF SCIENTIFIC OFFICERSell2,840Common Stock$31.11$88,352.40  0.52     [ Average ]200,944$6,251,367.84  36.86    [High]Form 4
2021-01-14Matthew StantonCHIEF SCIENTIFIC OFFICERSell2,790Common Stock$34.00$94,860.00  0.51     [ Average ]198,154$6,737,236.00  36.35    [High]Form 4
2021-01-14Tracy ZimmermannCHIEF DEVELOPMENT OFFICERBuy2,500Common Stock$4.59-$11,475.00  0.46     [ Average ]2,500$11,475.00  0.46     [Very Low]Form 4
2021-01-14Tracy ZimmermannCHIEF DEVELOPMENT OFFICERSell2,500Common Stock$33.09$82,725.00  0.46     [ Average ]0$0.00  -Form 4
2021-01-15Mark D. AngelinoCHIEF OPERATING OFFICERBuy7,500Common Stock$4.59-$34,425.00  1.38     [ High ]353,137$1,620,898.83  64.78    [High]Form 4
2021-01-15Mark D. AngelinoCHIEF OPERATING OFFICERSell3,500Common Stock$32.29$113,015.00  0.64     [ Average ]349,637$11,289,778.73  64.13    [High]Form 4
2021-01-15Mark D. AngelinoCHIEF OPERATING OFFICERSell2,900Common Stock$33.18$96,222.00  0.53     [ Average ]346,737$11,504,733.66  63.60    [High]Form 4
2021-01-15Mark D. AngelinoCHIEF OPERATING OFFICERSell500Common Stock$34.12$17,060.00  0.09     [ Very Low ]346,237$11,813,606.44  63.51    [High]Form 4
2021-01-15Mark D. AngelinoCHIEF OPERATING OFFICERSell600Common Stock$34.96$20,976.00  0.11     [ Low ]345,637$12,083,469.52  63.40    [High]Form 4